• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Natco Pharma Ltd.
    13 Jun 2025
    855.50
    -1.04%
    NATCO Pharma's Hyderabad API Manufacturing Facility Gets One Observation From USFDA
    NATCO Pharma's Hyderabad API Manufacturing Facility Gets One Observation From USFDA
    NDTV Profit
    The investigation was conducted from June 9 to June 13, 2025.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 385 to 317 in Jun 2025 qtr
    logo
    Jubilant Pharmova Ltd.
    13 Jun 2025
    1084.80
    -0.58%
    Why is Jubilant Pharmova share price buzzing in an overall weak market?
    Business Standard
    Jubilant Pharmova shares rose after its board approved the slump sale of its API business to wholly-owned subsidiary, Jubilant Biosys.
    Copy LinkShare onShare on Share on Share on
    Jubilant Pharmova Ltd. has gained 20.15% in the last 6 Months
    logo
    Eris Lifesciences Ltd.
    12 Jun 2025
    1634.90
    -0.33%
    Eris soars 11% on Thursday, zooms 61% from low; is it time to book profit?
    Business Standard
    The stock of the pharmaceutical company Eris Lifesciences was trading higher for the third straight day, soaring 17 per cent during the period.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 178 to 193 in Jun 2025 qtr.
    logo
    Mankind Pharma Ltd.
    12 Jun 2025
    2564.30
    -1.18%
    Nirmal Bang Maintains 'Hold' On Mankind Pharma Shares, Revises Target Price Here's Why
    Nirmal Bang Maintains 'Hold' On Mankind Pharma Shares, Revises Target Price Here's Why
    NDTV Profit
    Nirmal Bang maintain Hold rating on Mankind Pharma with a revised target price of Rs 2,650, valuing it at 25x on FY27E EV/Ebitda.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. is trading above its 200 day SMA of 2507.7
    logo
    OneSource Specialty Pharma Ltd.
    11 Jun 2025
    1781.80
    -1.12%
    OneSource Specialty Pharma partners with Swedish biotech company Xbrane, on its biosimilar portfolio
    Business Line
    As part of the agreement, Xbrane will undertake a tech-transfer of its commercial product to OneSource's integrated drug substance and drug product facility in Bengaluru
    Copy LinkShare onShare on Share on Share on
    OneSource Specialty Pharma Ltd. is trading below all available SMAs
    logo
    Marksans Pharma Ltd.
    11 Jun 2025
    Drug Approval
    171.32
    -1.68%
    Marksans Pharma shares surge 5% after block trades; details here
    Business Standard
    Marksans Pharma shares rose 5 per cent after 10.27 million shares changed hands via multiple pre-market block trades
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 153 to 159 in Jun 2025 qtr.
    logo
    Sun Pharmaceutical Industries Ltd.
    11 Jun 2025
    1631.20
    -0.78%
    'Buy' Sun Pharma Shares Maintains Nirmal Bang, Says India, Specialty To Drive Growth
    'Buy' Sun Pharma Shares Maintains Nirmal Bang, Says India, Specialty To Drive Growth
    NDTV Profit
    Nirmal Bang maintains Buy rating underpinned by Sun Pharma's strong positioning as a unique play on both the India branded market and the global specialty pharma opportunity.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below its 50 day SMA of 1638.0
    logo
    OneSource Specialty Pharma Ltd.
    10 Jun 2025
    1781.80
    -1.12%
    Mukul Agrawal portfolio stock hits record high; zooms 75% from March low
    Business Standard
    Shares of OneSource Specialty Pharma hit a new high of 2,031.45 in Tuesday's intra-day trade in otherwise a subdued market and rallied 28% in the past month
    Copy LinkShare onShare on Share on Share on
    OneSource Specialty Pharma Ltd. is trading below all available SMAs
    logo
    Glenmark Pharmaceuticals Ltd.
    10 Jun 2025
    Board Meeting
    2016.80
    -0.05%
    Glenmark Pharma rises 2% as company to launch blood cancer treatment drug
    Business Standard
    Glenmark Pharma shares gained 2 per cent in trade as company announced the upcoming launch of zanubrutinib, under the brand name Brukinsa in India
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. is trading below its 30 day SMA of 2019.0
    logo
    Dr. Reddy's Laboratories Ltd.
    07 Jun 2025
    1308.40
    0.54%
    Dr. Reddy's Laboratories: Holding on to a sweet promise
    Business Line
    The transition from Revlimid led growth to diabetes portfolio will be rocky yet rewarding
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • GK Energy
    • Saatvik Green Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd